Stock ENTA ENANTA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
15.17 USD +9.06% Intraday chart for Enanta Pharmaceuticals, Inc. +22.64% +61.21%
04-30 Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer CI
02-09 Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ENANTA PHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
+9.06%+22.64%+61.21%-58.21%-82.93% 321M
Neutral
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ENTA Stock
  4. Charts Enanta Pharmaceuticals, Inc.
  5. Comparison Chart